By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Food and Drug Administration today issued two preliminary reports providing an assessment of the 510(k) program and evaluating the agency's use of science in decision-making.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.